Finasteride vs Topical Minoxidil: Switching Between Them
HealthRX.com
Switching between finasteride and minoxidil: what the labels say
Key numbers
- 94.1%Men who improved at 12 months on finasteride plus minoxidil together (vs 80.5% finasteride alone, 59% minoxidil alone)Source: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
- 65%Drop in serum DHT a 1 mg finasteride tablet produces within 24 hoursSource: dailymed.nlm.nih.gov, as cited Nov 7, 2026
- 12 monthsTime after stopping finasteride within which its benefit reversesSource: dailymed.nlm.nih.gov, as cited Nov 7, 2026
- 2 monthsEarliest point men may see results from minoxidil; some need at least 4 monthsSource: dailymed.nlm.nih.gov, as cited Nov 7, 2026
From the public record
Registered clinical studies: finasteride and minoxidil
As of 2026-11-11, ClinicalTrials.gov lists 95 registered studies naming finasteride and 112 naming minoxidil as an intervention. 20 and 22 of them, in that order, are phase 3.
| Measure | Value |
|---|---|
| finasteride: registered studies | 95 |
| minoxidil: registered studies | 112 |
| finasteride: recruiting now | 6 |
| minoxidil: recruiting now | 13 |
| finasteride: completed | 62 |
| minoxidil: completed | 52 |
| finasteride: phase 3 studies | 20 |
| minoxidil: phase 3 studies | 22 |
How this was calculated
Searched the ClinicalTrials.gov intervention field for each name separately, downloaded every record and counted by status and phase.
Studies whose intervention field matches each name, any condition, all statuses; a study naming both is counted for each
Study counts show how much research is registered, not which drug works better or is safer. Older and more widely used drugs have more studies.
At a glance
- Finasteride form / prescription 1 mg tablet once daily, men only [1]
- Minoxidil form / over-the-counter topical; men's 5% solution twice daily, women's 5% foam once daily [2][3]
- Finasteride mechanism / type II 5-alpha-reductase inhibitor; 65% suppression of serum DHT within 24 hours [1]
- Minoxidil mechanism / potassium channel opener and vasodilator; hair-growth mechanism not fully understood [4]
- Time to benefit / finasteride 3 months or more [1]; minoxidil 2 to 4 months in men, about 3 to 6 months in women [2][3]
- On stopping / finasteride effect reverses within 12 months [1]; minoxidil hair loss begins again [2]
- Head-to-head / two randomized trials (65 and 450 men) favored finasteride over 5% minoxidil [5][6]
- Combination / 450-man trial: improvement in 94.1% on both drugs, 80.5% on finasteride alone, 59% on minoxidil alone [6]
How do finasteride and topical minoxidil differ?
Finasteride is a competitive, specific inhibitor of type II 5-alpha-reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT) [1]. Type II is found in hair follicles, among other tissues, and it drives about two-thirds of circulating DHT; a 1 mg tablet suppresses serum DHT by 65% within 24 hours, and finasteride has no affinity for the androgen receptor [1].
Topical minoxidil is a potassium channel opener and a vasodilator, and how it promotes hair growth is not fully understood [4].
The dosing differs in kind. Finasteride is one 1 mg tablet once daily, with or without food, and daily use for three months or more is usually needed before benefit is seen [1]. Men's 5% minoxidil solution is 1 mL applied with the dropper twice a day to the scalp in the hair loss area; using more or more often does not improve results [2]. Women's 5% minoxidil foam is half a capful once daily [3].
Which one works better in men?
Two randomized trials compared the drugs directly. Arca and colleagues randomized 65 men with androgenetic alopecia to finasteride 1 mg daily (40 men) or 5% topical minoxidil twice daily (25 men) for 12 months; increased hair intensity was seen in 80% (32 of 40) on finasteride and 52% (13 of 25) on minoxidil, and finasteride was judged more effective (P<0.05) [5]. The trial was open-label and small.
In a 450-man Chinese trial, patients took finasteride 1 mg (160 men), 5% topical minoxidil (130) or both (160); at 12 months, 80.5%, 59% and 94.1% respectively had improved, among 428 men evaluated [6].
Against placebo, the finasteride hair-loss program enrolled 1553 men aged 18 to 41 in two 1-year trials and compared 1 mg daily with placebo; hair count in a 1-inch (5.1 cm2) circle of vertex scalp was 107 hairs higher than placebo at 1 year and 138 higher at 2 years [7]. For minoxidil, a 48-week trial of 393 men found 5% solution superior to both 2% solution and placebo for nonvellus hair count, with more itching and local irritation on the 5% strength [8].
An evidence review using American College of Physicians grading concluded that oral finasteride (men only) and topical minoxidil (men and women) are the best-supported treatments for androgenetic alopecia [9].
Can you switch from finasteride to topical minoxidil?
No trial of a direct switch in either direction appears in the evidence for this comparison. What exists is the stopping timeline for each drug. For finasteride, the label says withdrawal leads to reversal of effect within 12 months, and in the vertex trials men switched from finasteride to placebo at 12 months lost the hair-count increase by 24 months [1]. On the minoxidil side, results may occur at 2 months, some men need at least 4 months, and the label says continued use is necessary or hair loss begins again [2]. Measurable changes from minoxidil disappear within months of discontinuation [4].
The men's 5% topical minoxidil solution is labeled for the top of the scalp only and is not intended for frontal baldness or a receding hairline [2]. For finasteride, the Propecia label says efficacy in bitemporal recession has not been established [1].
Can you switch from topical minoxidil to finasteride?
Finasteride's timeline is one 1 mg tablet daily, with three months or more of daily use usually needed before benefit is seen, and continued use to sustain benefit [1]. Propecia is prescription-only and labeled for men only [1].
One point belongs to minoxidil itself: increased hair loss can occur during minoxidil use because of synchronization of the hair cycle, and the shed hairs are usually replaced by thicker hairs in a new growth phase [4].
What people on Reddit report
Reddit accounts from r/tressless about moving between finasteride and minoxidil. These are mostly self-reported switches, with people describing what happened after changing.
They are very different. Perhaps you didn't respond to topical minox which is quite normal. You can boost the response by either adding tretinoin or switching to oral minox. In any case, keep the fin.Read the source discussion
I used topical min + fin for 3 years with great results. But I recently switched to oral fin because I realized by only applying to the hairline/crown, a good portion of my scalp was not receiving treatment. If I were you, I'd stick to oral, especially if you are seeing good results.Read the source discussion
I switched because its lot easier to just Take the pill. Its a bit of a hassle to Dose the finasterid and apply it evenly on the head. Its alcohol based so you basically have just a few seconds to rub it in before it drys out.Read the source discussion
Questions worth asking
What happens when finasteride is stopped?
The Propecia label states that withdrawal of treatment leads to reversal of effect within 12 months [1]. In the vertex trials, patients who changed from finasteride to placebo at 12 months had reversal of the hair-count increase 12 months later [1].
Can finasteride and topical minoxidil be used together?
A 450-man randomized trial tested the pair: 94.1% of men on both improved at 12 months versus 80.5% on finasteride and 59% on minoxidil [6]. The finasteride label states that no drug interactions of clinical importance have been identified and that finasteride does not appear to affect the cytochrome P450 system [1].
How do the side effects compare?
In three 12-month controlled trials of finasteride 1 mg (945 men on drug, 934 on placebo), drug-related decreased libido was 1.8% vs 1.3%, erectile dysfunction 1.3% vs 0.7% and ejaculation disorder 1.2% vs 0.7%; 3.8% vs 2.1% reported one or more of these (p=0.04), and 1.2% vs 0.9% stopped for sexual events [1]. The incidence of each fell to 0.3% or lower by year five [1].
The label's postmarketing section lists sexual dysfunction that continued after discontinuation, including erectile dysfunction, libido disorders, ejaculation disorders and orgasm disorders, and it lists depression, suicidal ideation and behavior; the label states that these voluntary reports come from a population of uncertain size and that a causal relationship cannot reliably be established [1][10]. Propecia carries no boxed warning [1]. Pregnancy is a contraindication in the Propecia label, and the label says women who are or may be pregnant should not handle crushed or broken tablets because of risk to a male fetus [1].
The men's 5% minoxidil Drug Facts warnings cover scalp irritation or redness, unwanted facial hair growth, chest pain, rapid heartbeat, faintness or dizziness, sudden unexplained weight gain, and swelling of the hands or feet [2]. In a 48-week trial of 381 women with female pattern hair loss, the 5% solution produced more itching, irritation and hypertrichosis than 2% solution or placebo [11].
Which product is labeled for which patient?
Finasteride 1 mg is indicated for male pattern hair loss in men only and is not indicated for women [1]. The men's 5% minoxidil solution is for men only and for the vertex [2]. The women's 5% foam is half a capful once daily, with results at about 3 months and up to 6 months for some women [3]. The 2% minoxidil solution has been sold over the counter since its Rx-to-OTC switch was approved on February 9, 1996 [12].
Check what you know
Question 1 of 5
Score: 0 right, 0 of 5 answered
Frequently asked questions
Can I switch from finasteride to topical minoxidil?
Will I lose the hair I gained if I stop finasteride?
Can finasteride and minoxidil be used at the same time?
Does topical minoxidil cause sexual side effects?
Which one shows results first?
Is topical minoxidil available without a prescription?
References
Show all 15 referencesHide references
- U.S. National Library of Medicine, DailyMed. Propecia (finasteride 1 mg) tablets, Organon prescribing information. Propecia (finasteride 1 mg) tablets, Organon label
- U.S. National Library of Medicine, DailyMed. Men's Rogaine Extra Strength minoxidil 5% topical solution, Kenvue prescribing information. Men's Rogaine Extra Strength minoxidil 5% topical solution, Kenvue label
- U.S. National Library of Medicine, DailyMed. Women's Rogaine minoxidil 5% topical foam, Kenvue prescribing information. Women's Rogaine minoxidil 5% topical foam, Kenvue label
- Rossi A, Cantisani C, Melis L, Iorio A, Scali E, Calvieri S. Minoxidil use in dermatology, side effects and recent patents. Recent Pat Inflamm Allergy Drug Discov. 2012;6(2):130-6.
- Arca E, Açikgöz G, Taştan HB, Köse O, Kurumlu Z. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia. Dermatology. 2004;209(2):117-25.
- Hu R, Xu F, Sheng Y, Qi S, Han Y, Miao Y, et al. Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients. Dermatol Ther. 2015;28(5):303-8.
- Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, et al. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol. 1998;39(4 Pt 1):578-89.
- Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002;47(3):377-85.
- Varothai S, Bergfeld WF. Androgenetic alopecia: an evidence-based treatment update. Am J Clin Dermatol. 2014;15(3):217-30.
- U.S. Food and Drug Administration.
- Lucky AW, Piacquadio DJ, Ditre CM, Dunlap F, Kantor I, Pandya AG, et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol. 2004;50(4):541-53.
- Drugs@FDA: FDA-Approved Drugs.
- Reddit participants. Replacing minoxidil with finasteride (r/tressless). Accessed 2026-11-10.
- Reddit participants. Switching from oral to topical (r/tressless). Accessed 2026-11-10.
- Reddit participants. Update Month 4 - switched finasterid topical to oral + Minoxidil topical (r/tressless). Accessed 2026-11-10.